MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 10, 2014, Pages 3811-3816

  Ogata, Takehiro ^a   Naito, Daisuke ^a   Nakanishi, Naohiko ^a   Hayashi, Yukiko K ^b   Taniguchi, Takuya ^a   Miyagawa, Kotaro ^a   Hamaoka, Tetsuro ^a   Maruyama, Naoki ^a   Matoba, Satoaki ^a   Ikeda, Koji ^a   Yamada, Hiroyuki ^a   Oh, Hidemasa ^c   Ueyama, Tomomi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Caveola; Heart; Plasma membrane; Signal transduction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CYCLOHEXIMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCLE RESTRICTED COILED COIL PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLUORESCENCE; GENE OVEREXPRESSION; HEART MUSCLE; HEART MUSCLE CELL; HEART SIZE; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSVERSE TUBULAR SYSTEM; VASCULAR SMOOTH MUSCLE; WILD TYPE;

CAVEOLA; HEART; PLASMA MEMBRANE; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; CAVEOLAE; DNA PRIMERS; ECHOCARDIOGRAPHY; IMMUNOPRECIPITATION; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MUSCLE PROTEINS; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, ALPHA-1; RNA INTERFERENCE;

EID: 84896280898     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315359111     Document Type: Article

References (38)

1. Shaul PW, Anderson RG (1998) Role of plasma lemma l caveolae in signal transduction. Am J Physiol 275(5 Pt 1):L843-L851.
2. Parton RG, Simons K (2007) The multiple faces of caveolae. Nat Rev Mol Cell Biol 8(3): 185-194.
3. Razani B, Woodman SE, Lisanti MP (2002) Caveolae: From cell biology to animal physiology. Pharmacol Rev 54(3):431-467.
4. Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84(4):1341-1379.
5. Harvey RD, Calaghan SC (2012) Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J Mol Cell Cardiol 52(2): 366-375.
6. Hansen CG, Nichols BJ (2010) Exploring the caves: Cavins, caveolins and caveolae. Trends Cell Biol 20(4): 177-186.
7. Briand N, Dugail I, Le Lay S (2011) Cavin proteins: New players in the caveolae field. Biochimie 93(1):71-77.
8. Williams TM, Lisanti MP (2004) The Caveolin genes: From cell biology to medicine. Ann Med 36(8):584-595.
9. Gratton JP, Bernatchez P, Sessa WC (2004) Caveolae and caveolins in the cardiovas cular system. Ore Res 94(11):1408-1417.
10. Bastiani M, et al. (2009) MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol 185(7):1259-1273.
11. Ogata T, et al. (2008) MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol Cell Biol 28(10):3424-3436.
12. Rodriguez G, etal. (2011) Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy. Circ Cardiovasc Genet 4(4):349-358.
13. McMahon KA, et al. (2009) SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J 28(8):1001-1015.
14. Hayashi YK, et al. (2009) Human PTRF mutations cause secondary deficiency of cav eolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119(9):2623-2633.
15. Bastiani M, Parton RG (2010) Caveolae at a glance. J Cell Sci 123(Pt 22):3831-3836.
16. Hill MM, et al. (2008) PTRF-Cavin, a conserved cytoplasmic protein required for cav-eola formation and function. Cell 132(1):113-124.
17. Hansen CG, Bright NA, Howard G, Nichols BJ (2009) SDPR induces membrane curva ture and functions in the formation of caveolae. Nat Cell Biol 11 (7):807-814.
18. Allen JA, Halverson-Tamboli RA, Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8(2):128-140.
19. Woodman SE, et al. (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277(41):38988-38997.
20. Jensen BC, Swigart PM, De Marco T, Hoopes C, Simpson PC (2009) α1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail 2(6):654-663.
21. Breitwieser GE (2004) G protein-coupled receptor oligomerization: Implications for G protein activation and cell signaling. Circ Res 94(1):17-27.
22. Fujita T, et al. (2001) Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: Caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 51(4):709-716.
23. O'Connell TD, et al. (2003) The α(1A/C)-and α(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 111(11):1783-1791.
24. Muslin AJ (2008) MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets. Clin Sci (Lond) 115(7):203-218.
25. Liu P, Ying Y, Anderson RG (1997) Platelet-de rived growth factor activates mitogen-ac-tivated protein kinase in isolated caveolae. Proc Natl Acad Sci USA 94(25):13666-13670.
26. Kholodenko BN, Hancock JF, Kolch W (2010) Signalling ballet in space and time. Nat Rev Mol Cell Biol 11 (6):414-426.
27. Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T (2002) The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9(5):945-956.
28. Bueno OF, etal. (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19(23):6341-6350.
29. Nabi IR (2009) Cavin fever: Regulating caveolae. Nat Cell Biol 11(7):789-791.
30. Liu L, et al. (2008) Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 8(4):310-317.
31. Hansen CG, Shvets E, Howard G, Riento K, Nichols BJ (2013) Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. Nat Commun 4:1831.
32. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP (2007) Scaffold proteins of MAP-kinase modules. Oncogene 26(22):3185-3202.
33. Petrashevskaya NN, Bodi I, Koch SE, Akhter SA, Schwartz A (2004) Effects of α1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression. Cardiovasc Res 63(3):561-572.
34. Koga A, et al. (2003) Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 42(2):213-219.
35. Wright CD, et al. (2008) Nuclear α1-adrenergic receptors signal activated ERK locali zation to caveolae in adult cardiac myocytes. Circ Res 103(9):992-1000.
36. Glennon PE, et al. (1996) Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulatesthe phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 78(6):954-961.
37. Kehat I, Molkentin JD (2010) Extracellular signal-regulated kinase 1/2 (ERK1/2) sig naling in cardiac hypertrophy. Ann N Y Acad Sci 1188:96-102.
38. Kehat I, et al. (2011) Extracellular signal-regulated kinases 1 and 2 regulate the bal ance between eccentric and concentric cardiac growth. Circ Res 108(2):176-183.